Viewing Study NCT03374332


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-25 @ 7:26 PM
Study NCT ID: NCT03374332
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-08
First Post: 2017-11-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Brown University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module